These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 16519520

  • 1. Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity.
    Arndt JW, Chai Q, Christian T, Stevens RC.
    Biochemistry; 2006 Mar 14; 45(10):3255-62. PubMed ID: 16519520
    [Abstract] [Full Text] [Related]

  • 2. Molecular mechanisms of substrate recognition and specificity of botulinum neurotoxin serotype F.
    Chen S, Wan HY.
    Biochem J; 2011 Jan 15; 433(2):277-84. PubMed ID: 21029044
    [Abstract] [Full Text] [Related]

  • 3. Botulinum neurotoxin serotype F: identification of substrate recognition requirements and development of inhibitors with low nanomolar affinity.
    Schmidt JJ, Stafford RG.
    Biochemistry; 2005 Mar 15; 44(10):4067-73. PubMed ID: 15751983
    [Abstract] [Full Text] [Related]

  • 4. Structural and biochemical characterization of the protease domain of the mosaic botulinum neurotoxin type HA.
    Lam KH, Sikorra S, Weisemann J, Maatsch H, Perry K, Rummel A, Binz T, Jin R.
    Pathog Dis; 2018 Jun 01; 76(4):. PubMed ID: 29688327
    [Abstract] [Full Text] [Related]

  • 5. Development of a fusion protein SNVP as substrate for assaying multi-serotype botulinum neurotoxins.
    Luo S, Li T, Wang Q, Tian R, Liu H, Fang H, Chen F, Wang H.
    Anal Biochem; 2014 Oct 15; 463():75-81. PubMed ID: 23851341
    [Abstract] [Full Text] [Related]

  • 6. Structural analysis of botulinum neurotoxin serotype F light chain: implications on substrate binding and inhibitor design.
    Agarwal R, Binz T, Swaminathan S.
    Biochemistry; 2005 Sep 06; 44(35):11758-65. PubMed ID: 16128577
    [Abstract] [Full Text] [Related]

  • 7. Structural and biochemical studies of botulinum neurotoxin serotype C1 light chain protease: implications for dual substrate specificity.
    Jin R, Sikorra S, Stegmann CM, Pich A, Binz T, Brunger AT.
    Biochemistry; 2007 Sep 18; 46(37):10685-93. PubMed ID: 17718519
    [Abstract] [Full Text] [Related]

  • 8. Crystal structure of botulinum neurotoxin type G light chain: serotype divergence in substrate recognition.
    Arndt JW, Yu W, Bi F, Stevens RC.
    Biochemistry; 2005 Jul 19; 44(28):9574-80. PubMed ID: 16008342
    [Abstract] [Full Text] [Related]

  • 9. Rapid product analysis and increased sensitivity for quantitative determinations of botulinum neurotoxin proteolytic activity.
    Rowe B, Schmidt JJ, Smith LA, Ahmed SA.
    Anal Biochem; 2010 Jan 15; 396(2):188-93. PubMed ID: 19782037
    [Abstract] [Full Text] [Related]

  • 10. Structure and activity of a functional derivative of Clostridium botulinum neurotoxin B.
    Masuyer G, Beard M, Cadd VA, Chaddock JA, Acharya KR.
    J Struct Biol; 2011 Apr 15; 174(1):52-7. PubMed ID: 21078393
    [Abstract] [Full Text] [Related]

  • 11. Substrate recognition strategy for botulinum neurotoxin serotype A.
    Breidenbach MA, Brunger AT.
    Nature; 2004 Dec 16; 432(7019):925-9. PubMed ID: 15592454
    [Abstract] [Full Text] [Related]

  • 12. Identification of the amino acid residues rendering TI-VAMP insensitive toward botulinum neurotoxin B.
    Sikorra S, Henke T, Swaminathan S, Galli T, Binz T.
    J Mol Biol; 2006 Mar 24; 357(2):574-82. PubMed ID: 16430921
    [Abstract] [Full Text] [Related]

  • 13. Specificity of botulinum protease for human VAMP family proteins.
    Yamamoto H, Ida T, Tsutsuki H, Mori M, Matsumoto T, Kohda T, Mukamoto M, Goshima N, Kozaki S, Ihara H.
    Microbiol Immunol; 2012 Apr 24; 56(4):245-53. PubMed ID: 22289120
    [Abstract] [Full Text] [Related]

  • 14. Crystal structure and novel recognition motif of rho ADP-ribosylating C3 exoenzyme from Clostridium botulinum: structural insights for recognition specificity and catalysis.
    Han S, Arvai AS, Clancy SB, Tainer JA.
    J Mol Biol; 2001 Jan 05; 305(1):95-107. PubMed ID: 11114250
    [Abstract] [Full Text] [Related]

  • 15. Structural basis of cell surface receptor recognition by botulinum neurotoxin B.
    Chai Q, Arndt JW, Dong M, Tepp WH, Johnson EA, Chapman ER, Stevens RC.
    Nature; 2006 Dec 21; 444(7122):1096-100. PubMed ID: 17167418
    [Abstract] [Full Text] [Related]

  • 16. A structural perspective of the sequence variability within botulinum neurotoxin subtypes A1-A4.
    Arndt JW, Jacobson MJ, Abola EE, Forsyth CM, Tepp WH, Marks JD, Johnson EA, Stevens RC.
    J Mol Biol; 2006 Sep 29; 362(4):733-42. PubMed ID: 16938310
    [Abstract] [Full Text] [Related]

  • 17. [Mechanisms of action of botulinum toxins and neurotoxins].
    Poulain B, Lonchamp E, Jover E, Popoff MR, Molgó J.
    Ann Dermatol Venereol; 2009 May 29; 136 Suppl 4():S73-6. PubMed ID: 19576489
    [Abstract] [Full Text] [Related]

  • 18. Botulinum neurotoxin serotype D attacks neurons via two carbohydrate-binding sites in a ganglioside-dependent manner.
    Strotmeier J, Lee K, Völker AK, Mahrhold S, Zong Y, Zeiser J, Zhou J, Pich A, Bigalke H, Binz T, Rummel A, Jin R.
    Biochem J; 2010 Oct 15; 431(2):207-16. PubMed ID: 20704566
    [Abstract] [Full Text] [Related]

  • 19. Light chain of botulinum neurotoxin serotype A: structural resolution of a catalytic intermediate.
    Fu Z, Chen S, Baldwin MR, Boldt GE, Crawford A, Janda KD, Barbieri JT, Kim JJ.
    Biochemistry; 2006 Jul 25; 45(29):8903-11. PubMed ID: 16846233
    [Abstract] [Full Text] [Related]

  • 20. Identification and characterization of a novel botulinum neurotoxin.
    Zhang S, Masuyer G, Zhang J, Shen Y, Lundin D, Henriksson L, Miyashita SI, Martínez-Carranza M, Dong M, Stenmark P.
    Nat Commun; 2017 Aug 03; 8():14130. PubMed ID: 28770820
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.